Personalized treatment could begin “within months,” according to the Gamaleya Center’s director

Russia’s first patients could begin receiving a newly developed cancer vaccine within the next few months.......The breakthrough drug is a personalized, AI-assisted, mRNA-based vaccine designed to target malignant tumors using the patient’s own genetic data.